Interim analysis results from a Proof-of-Concept study for ASLAN004 in adult moderate-to-severe atopic dermatitis: a double blind, randomized, placebo-controlled study

Karen A. Veverka , Kenneth Kobayashi, Josemund Menezes , Nicola McIntyre, Alison Ward, April Armstrong, Steven Tien Guan Thng, Jonathan I. Silverberg

Winter Clinical Dermatology Conference, January 2022